BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24074513)

  • 1. C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease.
    Sonmez M; Kazaz N; Yucel B; Topbas M; Ucar F
    Hematology; 2014 Jun; 19(4):213-6. PubMed ID: 24074513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density.
    Vidal C; Formosa R; Xuereb-Anastasi A
    J Mol Endocrinol; 2011 Dec; 47(3):327-33. PubMed ID: 21994215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors influencing the risk of multiple myeloma bone disease.
    Johnson DC; Weinhold N; Mitchell J; Chen B; Stephens OW; Försti A; Nickel J; Kaiser M; Gregory WA; Cairns D; Jackson GH; Hoffmann P; Noethen MM; Hillengass J; Bertsch U; Barlogie B; Davis FE; Hemminki K; Goldschmidt H; Houlston RS; Morgan GJ
    Leukemia; 2016 Apr; 30(4):883-8. PubMed ID: 26669972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone.
    Beyens G; Daroszewska A; de Freitas F; Fransen E; Vanhoenacker F; Verbruggen L; Zmierczak HG; Westhovens R; Van Offel J; Ralston SH; Devogelaer JP; Van Hul W
    J Bone Miner Res; 2007 Jul; 22(7):1062-71. PubMed ID: 17388729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients.
    Yin LL; Jing N; Zhao ZY; Liu XH; Du J; Qin LL; Song JG; Xu Y
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):37-41. PubMed ID: 28121359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
    Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
    Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
    Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
    Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
    Daroszewska A; Hocking LJ; McGuigan FE; Langdahl B; Stone MD; Cundy T; Nicholson GC; Fraser WD; Ralston SH
    J Bone Miner Res; 2004 Sep; 19(9):1506-11. PubMed ID: 15312251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
    Mencej-Bedrač S; Preželj J; Marc J
    Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
    Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
    J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis.
    Huang CH; Wei JC; Hung PS; Shiu LJ; Tsay MD; Wong RH; Lee HS
    Rheumatology (Oxford); 2011 Feb; 50(2):359-65. PubMed ID: 20974615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
    Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
    Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
    Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo.
    Ai LS; Sun CY; Wang YD; Zhang L; Chu ZB; Qin Y; Gao F; Yan H; Guo T; Chen L; Yang D; Hu Y
    Int J Cancer; 2013 Sep; 133(5):1074-84. PubMed ID: 23420490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
    Andersen NF; Vogel U; Klausen TW; Gimsing P; Gregersen H; Abildgaard N; Vangsted AJ
    Eur J Haematol; 2015 Jan; 94(1):60-6. PubMed ID: 24954766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
    Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
    J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability.
    Straface G; Biscetti F; Pitocco D; Bertoletti G; Misuraca M; Vincenzoni C; Snider F; Arena V; Stigliano E; Angelini F; Iuliano L; Boccia S; de Waure C; Giacchi F; Ghirlanda G; Flex A
    Stroke; 2011 Nov; 42(11):3022-8. PubMed ID: 21903966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
    Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
    Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.